Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Lakeshore Bone and Joint Institute has been selected as one of the 45 U.S. sites for a new clinical study evaluating the use of mesenchymal precursor cells (a type of stem cells) in subjects with ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...